Hayfever (Hyland’s)


Welcome to the PulseAid listing for the Hayfever drug offered from Hyland’s. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.

LABELER NAME / MANUFACTURER: Hyland’s
NON-PROPRIETARY NAME: AMBROSIA ARTEMISIIFOLIA, EUPHRASIA STRICTA, ONION, and SCHOENOCAULON OFFICINALE SEED
SUBSTANCE NAME: AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; ONION; SCHOENOCAULON OFFICINALE SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, SOLUBLE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1997-05-27
END MARKETING DATE: 0000-00-00


Hayfever HUMAN OTC DRUG Details:

Item DescriptionHayfever from Hyland’s
LABELER NAME: Hyland’s
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 3; 3([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 1997-05-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54973-9138_55bb3eff-1a62-43fa-baa5-5bf49023343e
PRODUCT NDC: 54973-9138
APPLICATION NUMBER:

Other AMBROSIA ARTEMISIIFOLIA; EUPHRASIA STRICTA; ONION; SCHOENOCAULON OFFICINALE SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hyland’sHayfever